RECRUITING

Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage

Description

To provide a treatment of both actinic keratoses and photodamage within one treatment.

Study Overview

Study Details

Study overview

To provide a treatment of both actinic keratoses and photodamage within one treatment.

Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage

Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage

Condition
Actinic Keratoses
Intervention / Treatment

-

Contacts and Locations

Victor

Rochester Dermatologic Surgery, Victor, New York, United States, 14564

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Over 18yrs of age
  • * Willingness to participate in all required study activities and visits
  • * Willingness to sign the informed consent form
  • * Visible and palpable signs of diffuse actinic damage and actinic keratoses of mild to moderate severity located on the face
  • * Significant signs of photoaging, evaluated by investigator, that include any or all the following:
  • * Dyspigmentation
  • * Solar lentigines
  • * Telangiectasias
  • * Diffuse erythema
  • * Roughness and other textural changes
  • * Fine lines
  • * Wrinkles
  • * Actinic bronzing
  • * Subject who is unable and unwilling to provide consent for study schedule and procedures
  • * Subject who is pregnant or trying to become pregnant during the study
  • * Subjects using any topical treatment on their AKs; must stop at least one month prior
  • * Subjects currently undergoing cancer treatment with medical or radiation therapy
  • * Subjects with a known hypersensitivity to 5-aminolevulinic acid or any component of the study material
  • * Subjects with history of a photosensitivity disease, such as porphyria cutanea tarda

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Sherrif Ibrahim,

Study Record Dates

2026-02-01